Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Bottom line: interesting scienceno proven human benefit, and unknown long-term safety
If lower-cost versions of GLP-1 therapies enter the market, healthcare organizations may gain more flexibility in expanding treatment access
Additionally, Ozempic, Wegovy, Mounjaro and Zepbound will be available at $245 for patients on Medicare with a copay of $50 per month as soon as April 1, 2026
The drug has a mild and gradual, but super-effective effect: in a month you can reduce weight by 2-7 kilograms
Neal recommends: Regular monitoring: Weighing yourself at least once a week
At Elysium Chicago , we offer FDA-approved GLP-1 treatments such as Semaglutide (brand names Ozempic and Wegovy) and Tirzepatide (brand name Mounjaro)
